Funds trio key shareholders in Open Orphan merger firm
A trio of London funds have emerged as major shareholders in Venn Life Sciences as part of its merger with Open Orphan.
The company announced last week that it has raised £4.5 million (€5 million) from investors to fund the reverse takeover of Dublin-based Open Orphan.
According to regulatory filings on Friday, Miton Asset Management and Crux Asset Management will each own 3.5 per cent of Open Orphan after the fundraising is complete. Livingbridge, a venture capital...
Subscribe from just 1€
Choose the subscription that is right for you
For the first month
€19.99 Monthly ThereafterSubscribe today
For the first year
€199.99 annually thereafterSubscribe today
For the first 90 days
€55.00 quarterly ThereafterSubscribe today
These offers are not available for current subscribers. Offers and pricing are subject to change without notice.
Terms & Conditions Apply